---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-159060"
form_type: "8-K"
ticker: "MYO"
cik: "0001369290"
company_name: "MYOMO, INC."
filed_at: "2026-04-16T23:59:59+00:00"
generated_at: "2026-05-15T05:44:26.122029+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Myomo appoints William J. Febbo to Board, effective April 14, 2026

## Summary
- Febbo, 57, is CEO of Performance Health Systems and former CEO of OptimizeRx (OPRX), where he grew revenue from $5M to $92M.
- He received 45,000 RSUs vesting on first anniversary, plus $60K annual cash retainer and $85K annual RSU retainer.
- Appointment expands Board to six directors; Febbo serves as Class II director until 2028 annual meeting.
- Chairman Paul Gudonis cited Febbo's expertise in scaling direct-to-patient healthcare and capital markets credibility.
- Febbo co-founded Merriman Holdings and Digital Capital Network; also MIT linQ faculty and Harvard Business School mentor.

## SEC filing metadata
- accession: 0001193125-26-159060
- form_type: 8-K
- ticker: MYO
- cik: 0001369290
- company_name: MYOMO, INC.
- filed_at: 2026-04-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369290/000119312526159060/0001193125-26-159060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369290/000119312526159060/myo-20260414.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-159060
- JSON: https://secwatch.observer/filing/0001193125-26-159060.json
- Plain text: https://secwatch.observer/filing/0001193125-26-159060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.